Genomictree Inc. Genomictree Inc.

Genomictree Inc.

228760

Classificação em ações #19128
Genomictree Inc. is a molecular diagnostics firm that harnesses biomarkers to... Genomictree Inc. is a molecular diagnostics firm that harnesses biomarkers to develop and market advanced detection tools for both oncological conditions and various infectious diseases. Its product line includes EarlyTect C, a screening solution for the early identification of colorectal cancer. For lung cancer, it offers EarlyTect L, which targets epigenetic markers in patients with pulmonary nodules, and for bladder cancer, EarlyTect B, designed to detect specific genetic and epigenetic markers in individuals with hematuria. The company also provides a range of companion diagnostics: AccuraTect-KRAS and AccuraTect-BRAF assist in colorectal cancer management, while AccuraTect-EGFR supports lung cancer treatment. In addition, Genomictree supplies AccuraDTect SARS-CoV-2 RT-qPCR kits for infectious disease testing, and offers its technologies to support various diagnostic test providers. Founded in 2000, the company is based in Daejeon, South Korea.
Preço da ação
$6.58
Valor de mercado
$161.41M
Variação (1 dia)
-0.63%
Variação (1 ano)
-50.29%
País
KR
Negociar Genomictree Inc. (228760)

Categoria

Healthcare
Histórico de desdobramentos de ações de Genomictree Inc. (228760)
As ações Genomictree Inc. (símbolo: 228760) passaram por um total de 0 desdobramentos.
O desdobramento mais recente ocorreu em Oct 21, 2026.
Uma ação 228760 comprada antes de Oct 21, 2026 equivaleria hoje a 0 ações 228760.
Lista de desdobramentos de ações
Ano Desdobramento Multiplicador Multiplicador cumulativo
Não há dados suficientes para as datas fornecidas.
Desdobramentos de ações de empresas semelhantes ou concorrentes
Empresa Número de desdobramentos de ações Multiplicador cumulativo País
1 x2
US
0 -
US
1 x3
AU
0 -
NL
0 -
CH